Skip to content

Just Got 510(k) Clearance? What to Do in the First 90 Days

Last reviewed November 7, 2026

Direct answer

After a 510(k) clearance, a device company may say its device is "FDA cleared" for the indications for use in its clearance letter, and nothing beyond them. It may never call a 510(k) device "FDA approved"; that word belongs to devices approved through premarket approval (PMA). The first 90 days usually cover five jobs: put the cleared indication into one approved set of claims, announce the clearance, make the website, IFU and label say the same thing, build the sales materials buyers ask for, and start a measured 90-day marketing test.

Read your clearance letter first

Your clearance letter and its Indications for Use statement (Form FDA 3881) set the limit for every claim you make. Copy the indications statement word for word into one document; that sentence is what your website, IFU, deck, ads and sales team may promote.

Then look up your record in the FDA 510(k) database by K number. The trade name, product code and indication listed there are what hospital buyers and value analysis committees check against your materials, so your materials must match it. You can also see who else cleared a similar device this year on the list of recent FDA 510(k) clearances.

Promoting a use outside the letter is not a wording problem. FDA treats your advertising and sales statements as evidence of the device's intended use (21 CFR 801.4), and a major change in intended use requires a new 510(k) (21 CFR 807.81(a)(3)). In 2023 FDA sent iRhythm Technologies a warning letter that cited, among other issues, marketing a monitor for "high-risk patients" when its clearance covered non-critical care patients.

What you can say now, and what you cannot

You can say the device is FDA cleared for the indication as written. Any wording that suggests FDA approved, endorsed or certified it is misleading under 21 CFR 807.97.

SayDo not say
FDA clearedFDA approved
510(k) clearedFDA certified
Cleared by the FDA for [indication as written in the letter]FDA endorsed
Received 510(k) clearance from the U.S. Food and Drug Administration"FDA registered" as a claim about the product (21 CFR 807.39)
Your K number, if you choose to show itThe FDA logo (FDA name and logo policy)
Any indication, patient group or setting not in the letter
Better, safer or faster than a named competitor without head‑to‑head data

For the full wording guide, read FDA cleared vs FDA approved. For claims beyond regulatory status (clinical data, comparisons, testimonials), read 510(k) marketing claims. For other pathways, read De Novo and PMA wording.

Announcing the clearance

Announce once you hold the signed substantial equivalence (SE) letter. Until then the device may not be marketed (21 CFR 807.100(a); FDA, Premarket Notification 510(k)). FDA sets no other rule on when you announce, and you do not need to wait for the clearance to appear in the FDA database.

The release must include:

The release must not include:

Post it on your own newsroom page first, so the wire story and press coverage link back to you. Then send it on the wire, pitch it to trade press for your specialty, and have the founders post it on LinkedIn in their own words, using the same cleared wording.

If your company is publicly traded, your securities disclosure rules decide when and how the news is released. Read medical device press releases that get picked up for headline and distribution detail.

Make the website, IFU and label say the same thing

Your website, IFU, label, sales deck and booth graphics must describe one device with one indication. If they differ, a buyer or an FDA reviewer will notice the version that goes furthest.

Read labeling and IFU requirements for what the label and IFU must contain.

Sales materials buyers ask for

What you build depends on how your device is sold. Most companies have one main route for the first 90 days.

The 30/60/90 plan

The plan below assumes the claims bank comes first, because every page, ad and email after it draws from that document.

DaysWhat gets done
1 to 30Claims bank signed. You own every ad, analytics and LinkedIn account in your company's name. Tracking proven on one real request or order. One conversion page per product. The clearance announcement.
31 to 60Brand search ads so your company name is not bought by a competitor. One paid channel aimed at the people who buy; LinkedIn for clinicians and committee members. A before and after campaign for your next conference. Follow‑up email to everyone who asked.
61 to 90Results read at day 45 and day 90 from your own CRM or store records, not the ad platform's numbers. Each channel is kept, changed or stopped.

If you have not cleared yet, start with the 90 days before clearance.

What it costs

Most work starts with a 90-day plan and test, from $5,000. Ongoing programs start at $2,500 a month. The 90-day plan and test covers the plan, the first work in market and written reports at day 45 and day 90. Ad spend is paid on your own card, directly to Google, LinkedIn or the other platforms, and is not part of these fees.

Where you land depends on how many channels you run, how many products you launch and how much claim review your regulatory team needs.

Hiring an agency after clearance: four questions

Ask each agency these four questions before you sign:

  1. Will you check every claim against our clearance letter? Ask to see how they do it.
  2. Will we own every account and all the data? Ad, analytics and LinkedIn accounts should be in your company's name, with the agency added as a user.
  3. How will results be judged? The answer should be your CRM or store records, not the ad platform's own reports.
  4. Who does the work? Ask for the names of the people who will write and run it.

Buzzbox Media built the brand identity, website and trade show presence for the launch of True Digital Surgery, a B. Braun company, and its surgical visualization platform (case study).

To talk through your launch, book a free 30-minute call with Baron Miller. See Buzzbox Media's medical device branding and medical device marketing services.

Frequently asked questions

Can I say "FDA approved" after 510(k) clearance?

No. A 510(k) clearance means FDA found your device substantially equivalent to a device already on the market. It is not an approval, and 21 CFR 807.97 says any statement creating an impression of official approval because of a 510(k) is misleading. Say "FDA cleared" or "510(k) cleared." "FDA approved" is correct only for a device approved through premarket approval (PMA).

When can I announce my 510(k) clearance?

Once you hold the signed substantial equivalence letter from FDA. You do not need to wait for the clearance to show in the FDA 510(k) database. Quote the cleared indication in the release, put "510(k) clearance" in the headline and never use "approved." If your company is publicly traded, follow your securities disclosure rules on timing.

Can I put the FDA logo on my website or packaging?

No. FDA's name and logo policy says no third party may use the FDA logo, or use it in connection with any third-party product or service, unless FDA authorizes it in writing or in a signed license agreement, and it may never be used to imply FDA endorsement. Clearance does not give you that authorization. State your status in words instead, for example "FDA cleared" or "510(k) cleared," with your K number if you want buyers to look it up.

How soon after clearance can I start selling?

FDA says the submitter may market the device immediately after 510(k) clearance is granted, for the cleared indications. Your establishment registration and device listing must also be in order: a company that has not registered before must register and list within 30 days of starting to manufacture, import or otherwise handle the device (21 CFR 807.20 and 807.22(a)). An already registered company can add the new device to its listing when it enters commercial distribution, and must report it no later than the annual October to December update (21 CFR 807.22(b)). In practice, the delay is usually your own materials: sell only after the website, IFU, label and sales deck match the letter.

Do I have to change my website and IFU after clearance?

Yes, if anything on them goes beyond or differs from the cleared indication. Remove "pending clearance" and "investigational" language from the cleared configuration only, and state the indication word for word on each product page. Your IFU, label, website, deck and booth graphics should all come from one set of approved sentences signed by your regulatory lead.

What does launch marketing cost after FDA clearance?

Most work starts with a 90-day plan and test, from $5,000. Ongoing programs start at $2,500 a month. Ad spend is paid on your own card, directly to Google, LinkedIn or the other platforms, and is not part of these fees. Where you land depends on how many channels you run, how many products you launch and how much claim review your regulatory team needs.

My device was granted De Novo. Is it "FDA cleared"?

No. A De Novo request is granted, not cleared, because the device has no predicate and FDA creates a new classification for it. Say the device was "authorized by FDA through the De Novo pathway" or "granted De Novo." Never say "FDA approved." Once granted, your device can serve as a predicate for future 510(k) submissions for devices of the same type, by you or others.

Sources

About Buzzbox Media

Buzzbox Media is a Franklin, TN-based medical device marketing agency founded in 2010 by Baron Miller. We work exclusively with medical device manufacturers, healthcare technology companies, and medical associations. Our services include FDA-compliant marketing strategy, healthcare SEO, PPC advertising, medical device branding, web design, email marketing, video production, and conference marketing. With over 15 years of experience in regulated healthcare markets, we help medical device companies in Franklin, Tennessee, and across the United States build marketing programs that drive surgeon adoption, hospital procurement, and market share growth.